Диссертация (1174289), страница 13
Текст из файла (страница 13)
Al-Hakim, S.T. Kee, K.Olinger, E.W. Lee, J.M. Moriarty, J.P. McWilliams // J VascIntervRadiol. 2014. - Vol. 25(6). - P. 933-939.44.Andreoli, J.M. Comparison of complication rate associated withpermanent and retrievable inferior vena cava filters: a review of MAUDEDatabase / J.M. Andreoli, R.J. Lewandowski, R.L. Vogelzang, R.K. Ryu // JVascIntervRadiol. - 2014. - Vol. 25(8). - P. 1181-1185.45.Augustinos, P. Invasive approaches to treatment of venousthromboembolism / P. Augustinos, K.
Ouriel // Circulation. - 2004. Vol. 110(Supp 1). - P. 27-34.8946.Babu, S.H. Three-year experience of prophylactic placement ofinferior vena cava filters in women with gynecological cancer / S.H. Babu,A.M. Khan, P.J.B. Coates // International Journal of General Medicine. - 2013. Vol. 6. - P. 671-674.47.Bahl,V.Avalidationstudyofaretrospectivevenousthromboembolism risk scoring method / V. Bahl, H.M.
Hu, P.K. Henke et al. //Ann Surg. – 2009. - Vol. 241. - P.344–5048.Bakshi, P. Indications for and use of inferior vena cava filters in thepreoperative phase / P. Bakshi, J. Partridge // BMJ. - 2013. Vol. 347. - P. 1-4.49.Bates, S.M. Diagnosis of DVT: Antithrombotic therapy andprevention of thrombosis, 9th ed: American College of Chest Physiciansevidence-based clinical practice guidelines / S.M. Bates, R. Jaeschke, S.M.Stevens et al. // Chest. - 2012. - Vol. 141 (suppl 2). – P. 351–41850.Bauersachs,R.Oralrivaroxabanforsymptomaticvenousthromboembolism / R. Bauersachs, S.D. Berkowitz, B.
Brenner et al. // N. Engl.J. Med. - 2010. - Vol. 363 (26). – P. 2499–2510.51.Blute, M.L. The Mayo Clinic experience with surgical management,complications and outcome for patients with renal cell carcinoma and venoustumour thrombus / M.L. Blute, B.C. Leibovich, C.M. Lohse et al. // BJU Int. 2004. - Vol. 94. – P. 33-41.52.Byrne, M.
Inferior vena cava filter thrombosis / M. Byrne, G.N.Mannis, J. Nair, C. Andreadis // Clin Case Rep. – 2015. - Vol. 4(2). – P.162164.53.Caprini J.A. Risk assessment as a guide for the prevention of themany faces of venous thromboembolism. AmJSurg 2010. - Vol.
199. – P. 3–10.54.Cazan, I. Surgical treatment of postpartum iliofemoral deep veinthrombosis - case reports / I. Cazan, C. Strobescu, G. Baroi, S. Cazan, G. Lefter,R.F.Popa // Rev Med Chir Soc Med Nat Iasi. – 2016. - Vol. 120(2). – P. 384387.9055.Charalel, R.A. Deep Vein Thrombosis Interventions in CancerPatients / R.A. Charalel, S.
Vedantham // Semin Intervent Radiol. – 2017. Vol. 34(1). – P. 50-53.56.Chaudhry, M.A. Use of the trellis device in management of deepvein thrombosis: a retrospective single-center experience / M.A. Chaudhry, R.Pappy, T.A. // Hennebry J Invasive Cardiol. - 2013. - Vol. 25(6). – P. 269-278.57.Chiou, A.C. Intravascular ultrasound-guided bedside placement ofinferior vena cava filters / A.C.
Chiou // SeminVasc Surg. - 2006. - Vol. 19(3).– P. 150-4.58.Cohen, A.T. Venous thromboembolism (VTE) in Europe. Thenumber of VTE events and associated morbidity and mortality / A.T. Cohen, G.Agnelli, F.A. Anderson et al. // Thromb. Haemost. - 2007. - Vol. 98. – P.
756–764.59.Cushman, M. Epidemiology and risk factor for venous thrombosis /M. Cushman // SeminHematol. - 2007. - Vol. 44(2). – P. 62-69.60.Dobesh, P.P. Economic burden of venous thromboembolism inhospitalized patients / P.P. Dobesh // Pharmacotherapy. - 2009. - Vol. 29 (8):943–53.61.heparinsDolovich, L.R.
A meta-analysis comparing low-molecular-weightwithunfractionatedheparininthetreatmentofvenousthromboembolism: examining some unanswered questions regarding location oftreatment, product type, and dosing frequency / L.R. Dolovich, J.S. Ginsberg,J.D. Douketis et al. // Arch Intern Med. - 2000. - Vol. 160. -. P. 181– 188.62.Donnellan, E. Cancer and venous thromboembolic disease: frommolecular mechanism to clinical management / E.
Donnellan, B. Kevane, B.R.Healey Bird, F.Ni. Ainle // CurrOncol. - 2014. - Vol. 21. - P. 134-143.63.Franchini, M. New anticoagulants for treatment of venousthromboembolism / M. Franchini, P.M. Mannucci // Eur. J. Intern. Med. - 2012.- Vol. 23(8). – P. 692–695.9164.Geersing, G.J. Exclusion of deep vein thrombosis using the Wellsrule in clinically important subgroups: individual patient data meta-analysis /G.J Geersing, N.P.A.
Zuithoff, C. Kearon et al. // British Medical Journal. 2014. - Vol. 348. – P. 1340.65.Gould, M.K. Low-molecular-weight heparins compared withunfractionated heparin for treatment of acute deep venous thrombosis. A meta analysis of randomized, controlled trials / M.K. Gould, A.D. Dembitzer, R.L.Doyle et al. // Ann Intern Med. - 1999. - Vol. 130/ - P. 800 –80966.Greenfield, L.J. Vena caval filter use in patients with sepsis: resultsin 175 patients / L.J.
Greenfield, M.C. Proctor // Arch Surg. - 2003. - Vol.138(22). – P. 1245-1248.67.Guideline Summary NGC-8431. ACR-SIR practice guideline forperformance of inferior vena cava (IVC) filter placement for prevention ofpulmonary embolism. - 2011. - 13p.68.Gutt, C.N. Prophylaxis and treatment of deep vein thrombosis ingeneral surgery / C.N. Gutt et al.
// The American Journal of surgery. - 2005. Vol. 189. – P. 14-22.69.Hawes, E.M. Anticoagulation: managing adverse events in patientsreceiving anticoagulation and perioperative care / E.M. Hawes, A.J. Viera //FPessentials. - 2014. - Vol. 423.
– P. 31-39.70.Heit, J.A. The epidemiology of venous thromboembolism in thecommunity / J.A. Heit // ArteriosclerThromb. Vasc. Biol. - 2008. - Vol. 28. - P.370–372.71.Hirschl, M. New oral anticoagulants in treatment of acute venousthromboembolism – a systematic review with indirect comparisons / M. Hirschl,Kundi M. // Vasa. - 2014. - Vol. 43(5). – P. 353-364.72.Hislop, S.
Correlation of intravascular ultrasound and computedtomography scan measurements for placement of intravascular ultrasound guided inferior vena cava filters / S. Hislop, D. Fanciullo et al. // J Vasc Surg. 2014. - Vol. 59(4). – P. 1066-1072.9273.Hull, R.D. Subcutaneous low-molecular weight heparin comparedwith continuous intravenous heparin in the treatment of proximal-veinthrombosis / R.D. Hull, G.E. Raskob, G.F. Pineo et al. // N Engl J Med. - 1992.- Vol. 326. – P. 975–982.74.Hyers, T.M.
Antithrombotic therapy for venous thromboembolicdisease / T.M. Hyers, G. Agnelli, R.D. Hull et al. // Chest. 2001. - Vol. 119. – P.176–193.75.Jyothi, S. Acute iliofemoral thrombosis in broad ligament myoma /S. Jyothi // J ObstetGynecol India. - 2006. - Vol. 56. № 3. – P. 265-266.76.Kamphuisen, P.W. Bleeding complications during anticoagulanttreatment in patients with cancer / P.W. Kamphuisen, J. Beyer-Westendorf //Thromb Res.
- 2014. - Vol. 133. - Supp 2. – P. 49-55.77.Kasirajan, K. Percutaneous AngioJet thrombectomy in managementof extensive deep venous thrombosis / K. Kasirajan, B. Gray, K. Ouriel // JVascIntervRadiol. - 2001. - Vol. 12. – P. 179-185.78.Kearon, C. Antithrombotic therapy for VTE disease: antithrombotictherapy and prevention of thrombosis. American College of Chest Physiciansevidence-based clinical practice guidelines / C. Kearon, E.A. Akl, A.J.Comerota et al. // Chest.
– 2012. - Vol. 141(2). - P. 419–494.79.Kearon, C. Antithrombotic therapy for VTE disease: CHESTGuideline and expert panel report / C. Kearon, E.A. Akl, J. Ornelas et al. //CHEST. - 2016. - Vol 149. - № 2. – P. 315-352.80.Keisker, H.W. Results obtained by superficial femoral vein ligation/ H.W. Keisker, R.F. Browers // Surgery. - 1960.
- Vol. 47. – P. 224-229.81.Kohi, M.P. Catheter directed interventions for acute deep veinthrombosis / M.P. Kohi, R. Kohlbrenner, K.P. Kolli, E. Lehrman, A.G. Taylor,N. Fidelman // Cardiovasc Diagn Ther. – 2016. - Vol. 6(6). – P. 599-611.82.Kraf, C. Thrombosis of inferior vena cava and malignant disease /C. Kraf et al.
// ThrombRes. - 2014. - Vol. 134 (3). – P. 668-673.9383.Kudo, M. Utility of thrombophilia testing in patients with venousthromboembolism / M. Kudo, H.L. Lee, I.A. Yang, P.J. Masel // J Thorac Dis. 2016 - Vol. 8(12). – P. 3697-3703.84.Kuyumcu, G. Inferior vena cava filter retrievals, standard and noveltechniques / G. Kuyumcu, T.G. Walker // Cardiovasc Diagn Ther. - 2016 - Vol.6(6).
– P. 642-650.85.Kuwano, T. Venous thrombosis associated with a large uterinemyoma / T. Kuwano, S. Miura et al. // The Japanes Society of InternalMedicine. - 2008. - Vol. 47. – P. 809.86.Kyrle, P.A. Deep vein thrombosis / P.A. Kyrle, S. Eichinger //Lancet. - 2005. - Vol. 365 (9465). – P. 1163-1174.87.Lazar, J. Free-Floating Thrombus and Pulmonary Embolism / J.Lazar // Arch Intern Med. - 1997. - Vol.
157 (22). – P. 2661-2662.88.Lee, A.Y. Treatment of cancer-associated thrombosis: perspectiveson the use of novel oral anticoagulants / A.Y. Lee, M. Carrier // Thromb Res. 2014. - Vol. 133, Suppl 2. – P. 67-71.89.Lee, C.H. Venous thromboembolism: diagnosis and management ofpulmonary embolism / C.H. Lee, G.J. Hankey, W.K. Ho, J.W. Eikelboonr //Med.
J. Aust. - 2005. - Vol. 182. - № 11. – P. 569–574.90.Lee, J.H. The results of aspiration thrombectomy in theendovascular treatment for iliofemoral deep vein thrombosis / J.H. Lee, W.H.Kwun, B.Y. Suh // J Korean Surg Soc. - 2013. - Vol. 84. – P. 292-297.91.Levine, M. Hemorrhagic complications of anticoagulant treatment /M. Levine, G. Raskob, C. Kearon // Chest.
- 2001. - Vol. 119. – P. 108-121.92.Linkins, L.A. Clinical impact of bleeding in patients taking oralanticoagulant therapy for venous thromboembolism: a meta-analysis /L.A.Linkins, P.T. Choi, J.D. Douketis // Ann. Intern. Med. - 2003. - Vol. 139. - P.893–900.9493.Linkins, L.A. New and emerging anticoagulant therapies for venousthromboembolism / L.A. Linkins, J.I. Weitz // Curr. Treat.
Options Cardiovasc.Med. - 2010. - Vol. 12(2)/ - P. 142–155.94.Mahan, C.E. Deep-vein thrombosis: A United States cost model fora preventable and costly adverse event / C.E Mahan, M.T. Holdsworth, S.M.Welch et al. // ThrombHaemost. - 2011. - Vol. 106 (3). – P. 405–415.95.Martinelli, I. Recurrent venous thromboembolism and abnormaluterine bleeding with anticoagulant and hormone therapy use / I. Martinelli,A.W. Lensing, S.
Middeldorp // Blood. - 2016 - Vol. 127(11). – P. 1417-1425.96.McLafferty, R.B. The role of intravascular ultrasound in venousthromboembolism / R.B. McLafferty // SeminInterventRadiol. - 2012. - Vol.29(1). – P. 10-15.97.McLoney, E.D. Complications of Celect, Günter tulip, andGreenfield inferior vena cava filters on CT follow-up a single-institutionexperience / E.D. McLoney, V.P. Krishnasamy, J.C. Castle, X. Yang, G.